Nationwide Recall of Eye Ointments Over Infection Risk

FDA finds unsterile conditions at manufacturing plant, prompting recall of products sold at major retailers.

Four eye ointment products sold under the brands Equate, CVS Health, and AACE Pharmaceuticals have been recalled due to sterility concerns at the manufacturing facility in India.
The recall was initiated after the FDA found unsterile conditions at the plant, raising the risk of eye infections or related harm for users.
The affected products were distributed nationwide and include ointments with expiration dates ranging from February 2024 to September 2025.
Consumers are advised to stop using the recalled products immediately and can return them to the place of purchase for a refund.
This recall adds to a growing list of eye products recalled in recent months due to sterility and contamination concerns.